Mizuho Medy Co Ltd
TSE:4595

Watchlist Manager
Mizuho Medy Co Ltd Logo
Mizuho Medy Co Ltd
TSE:4595
Watchlist
Price: 2 289 JPY -0.82% Market Closed
Market Cap: 34.4B JPY
Section:
Relative Value
Relative Value
Valuation Multiples
Multiples Across Competitors
See Also

Relative Value

4595 price has not been updated for more than 1 year. This may indicate that the stock has been delisted.

The Relative Value of one Mizuho Medy Co Ltd stock under the Base Case scenario is 1 748.07 JPY. Compared to the current market price of 2 289 JPY, Mizuho Medy Co Ltd is Overvalued by 24%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
1 748.07 JPY
Overvaluation 24%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

3
P/S
P/S
Price to Sales
3
vs History
50
vs Industry
37
Median 3Y
2.8
Median 5Y
3
Industry
2.2
Forward
3.3
More Details
9.1
P/E
P/E
Price to Earnings
9.1
vs History
34
vs Industry
42
Median 3Y
7.6
Median 5Y
9
Industry
21.9
Forward
12.2
More Details
10.3
P/OCF
P/OCF
Price to OCF
10.3
vs History
42
vs Industry
35
Median 3Y
6.1
Median 5Y
10.3
Industry
13.5
More Details
11.3
P/FCFE
P/FCFE
Price to FCFE
11.3
vs History
42
vs Industry
31
Median 3Y
7.1
Median 5Y
11.3
Industry
19.3
More Details
2
P/B
P/B
Price to Book Value
2
vs History
90
vs Industry
42
Median 3Y
2.3
Median 5Y
2.7
Industry
2.1
More Details
2
EV/S
EV/S
Enterprise Value to Sales
2
vs History
71
vs Industry
48
Median 3Y
2.1
Median 5Y
2.2
Industry
2.3
Forward
2.2
More Details
2.9
EV/GP
EV/GP
Enterprise Value to Gross Profit
2.9
vs History
57
vs Industry
59
Median 3Y
2.8
Median 5Y
3
Industry
4.8
More Details
4.5
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
4.5
vs History
42
vs Industry
48
Median 3Y
4
Median 5Y
4.5
Industry
11.5
Forward
5.5
More Details
4.7
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
4.7
vs History
42
vs Industry
47
Median 3Y
4.1
Median 5Y
4.7
Industry
15.6
More Details
6.9
EV/OCF
EV/OCF
Enterprise Value to OCF
6.9
vs History
42
vs Industry
45
Median 3Y
5.6
Median 5Y
6.9
Industry
13.3
More Details
7.6
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
7.6
vs History
38
vs Industry
37
Median 3Y
5.7
Median 5Y
6.6
Industry
17.3
More Details
2.6
EV/IC
EV/IC
Enterprise Value to IC
2.6
vs History
90
vs Industry
30
Median 3Y
3
Median 5Y
3.7
Industry
1.8
More Details

Multiples Across Competitors

Competitors Multiples
Mizuho Medy Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
Market Cap P/S P/E EV/EBITDA EV/EBIT
JP
Mizuho Medy Co Ltd
TSE:4595
34.4B JPY 3 9.1 4.5 4.7
US
Abbott Laboratories
NYSE:ABT
232B USD 5.5 17.2 22.3 32
US
Intuitive Surgical Inc
NASDAQ:ISRG
191.7B USD 22 77.4 61.8 74.4
US
Boston Scientific Corp
NYSE:BSX
152.3B USD 8.7 74.9 35.3 49
US
Stryker Corp
NYSE:SYK
146.1B USD 6.3 51.1 25.3 30.5
IE
Medtronic PLC
NYSE:MDT
107.3B USD 3.2 25.2 13.5 19.1
DE
Siemens Healthineers AG
XETRA:SHL
52.1B EUR 2.3 26.2 15.2 21.7
US
Becton Dickinson and Co
NYSE:BDX
48.1B USD 2.3 31.7 12.8 23.9
US
Edwards Lifesciences Corp
NYSE:EW
43.9B USD 7.9 10.5 24 26.4
US
IDEXX Laboratories Inc
NASDAQ:IDXX
39.6B USD 10.1 44.2 31.4 35.1
CN
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
272.9B CNY 7.7 24.5 21.4 21.4

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 253,400+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.